Key result
Native T1 was raised in all hypertrophic conditions, while markedly raised native T2 was specific to chronic kidney disease compared to other groups, suggesting intramyocardial fluid.
Why the study?
Native T1 is a non-specific readout that may relate to increased intramyocardial fluid as well as diffuse fibrosis, prompting examination of concomitant T1 and T2 mapping signatures across hypertrophic conditions.
Can native T1 and T2 mapping by CMR differentiate between hypertrophic cardiac conditions (CKD, HTN, HCM)?
Observational (n=608)
Yes
Can native T1 and T2 mapping by CMR differentiate between hypertrophic cardiac conditions (CKD, HTN, HCM)?
Native T1 and T2 mapping provide distinct CMR signatures for hypertrophic conditions, with markedly raised native T2 being specific to CKD, suggesting intramyocardial fluid accumulation.
Answers are grounded in this paper and cite their sources.
Native T2 may differentiate CKD hypertrophy; leaves open intramyocardial fluid role pending validation.
AIMS: Profound left ventricular (LV) hypertrophy with diastolic dysfunction and heart failure is the cardinal manifestation of heart remodelling in chronic kidney disease (CKD). Previous studies related increased T1 mapping values in CKD with diffuse fibrosis. Native T1 is a non-specific readout that may also relate to increased intramyocardial fluid. We examined concomitant T1 and T2 mapping signatures and undertook comparisons with other hypertrophic conditions. METHODS: In this prospective multicentre study, consecutive CKD patients (n = 154) undergoing routine clinical cardiac magnetic resonance (CMR) imaging were compared with patients with hypertensive (HTN, n = 163) and hypertrophic cardiomyopathy (HCM, n = 158), and normotensive controls (n = 133). RESULTS: Native T1 was significantly higher in all patient groups, whereas native T2 in CKD only (p < 0.001 vs. all groups). Native T1 and T2 were interrelated in patient groups and the strength of association was condition-specific (CKD r = 0.558, HTN r = 0.324, both p < 0.001; HCM r = 0.157, p = 0.05). Native T1 and T2 were similarly correlated in all CKD stages (S3 r = 0.501, S4 0.586, S5 r = 0.424, p < 0.001 for all). Native T1 was the strongest myocardial discriminator between patients and controls (area under the curve, AUC HCM: 0.97; CKD: 0.97, HTN 0.98), native T2 between CKD vs HCM (AUC 0.90) and native T1 and T2 between CKD vs HTN (AUC: 0.83 and 0.80 respectively), p < 0.001 for all. CONCLUSIONS: Our findings reveal different CMR signatures of common hypertrophic cardiac phenotypes. Native T1 was raised in all conditions, indicating the presence of pathologic hypertrophic remodelling. Markedly raised native T2 was CKD-specific, suggesting a prominent role of intramyocardial fluid.
No takes yet. Share an insight, caveat, or question.
Arcari et al. (2020) conducted an observational in Hypertrophic cardiac conditions (CKD, HTN, HCM) (n=608). Chronic kidney disease vs. Hypertensive cardiomyopathy, hypertrophic cardiomyopathy, and normotensive controls was evaluated on Native T1 and T2 mapping values (p=<0.001). Native T1 was raised in all hypertrophic conditions, while markedly raised native T2 was specific to chronic kidney disease compared to other groups, suggesting intramyocardial fluid.
Synapse has enriched 10 related papers. Consider them for comparative context: